Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mary J. Burgess is active.

Publication


Featured researches published by Mary J. Burgess.


Open Forum Infectious Diseases | 2015

Long-Term Care Facilities Are Reservoirs for Antimicrobial-Resistant Sequence Type 131 Escherichia coli.

Mary J. Burgess; James R. Johnson; Stephen B. Porter; Brian Johnston; Connie Clabots; Brian D. Lahr; James R. Uhl; Ritu Banerjee

In this cross sectional study, one-fourth of LTCF residents were colonized intestinally with ST131 E. coli. The most dependent residents were at highest risk. Strain transmission occurred within and between LTCFs. Molecular typing showed similarities to clinical isolates.


Mayo Clinic Proceedings | 2013

Human Immunodeficiency Virus: What Primary Care Clinicians Need to Know

Mary J. Burgess; Mary J. Kasten

Human immunodeficiency virus (HIV) has evolved from an illness that consistently led to death to a chronic disease that can be medically managed. Primary care clinicians can provide beneficial care to the individual patient and potentially decrease the transmission of HIV to others through appropriate HIV screening and recognition of clinical clues to both chronic and acute HIV. Most patients who take combination antiretroviral therapy experience immune reconstitution and resume normal lives. These patients benefit from the care of an experienced primary care clinician in addition to a clinician with HIV expertise. Primary care clinicians have expertise providing preventive care, including counseling regarding healthier lifestyle choices and managing cardiovascular risk factors, osteoporosis, hypertension, and diabetes, all of which have become increasingly important for individuals with HIV as they age. This article reviews the many important roles of primary care clinicians with regard to the HIV epidemic and care of patients with HIV.


HIV/AIDS : Research and Palliative Care | 2015

Management of HIV/AIDS in older patients–drug/drug interactions and adherence to antiretroviral therapy

Mary J. Burgess; John D Zeuli; Mary J. Kasten

Patients with human immunodeficiency virus (HIV) are living longer with their disease, as HIV has become a chronic illness managed with combination antiretroviral therapy (cART). This has led to an increasing number of patients greater than 50 years old living successfully with HIV. As the number of older adults with HIV has increased, there are special considerations for the management of HIV. Older adults with HIV must be monitored for drug side effects and toxicities. Their other non-HIV comorbidities should also be considered when choosing a cART regimen. Older adults with HIV have unique issues related to medication compliance. They are more likely than the younger HIV patients to have vision loss, cognitive impairment, and polypharmacy. They may have lower expectations of their overall health status. Depression and financial concerns, especially if they are on a fixed income, may also contribute to noncompliance in the aging HIV population.


Case Reports in Medicine | 2015

A Case of Scopulariopsis brevicaulis Endocarditis with Mycotic Aneurysm in an Immunocompetent Host

Kelly Cawcutt; Larry M. Baddour; Mary J. Burgess

Scopulariopsis is a genus of mold that is usually associated with onychomycosis and rarely causes complicated infection in immunocompetent persons. We describe a case of an immunocompetent 65-year-old male with a history of mitral valve repair with prosthetic ring placement who developed acute left posterior knee pain. Imaging showed a left popliteal artery aneurysm and thrombus, and further evaluation with transesophageal echocardiogram demonstrated two large, mobile mitral valve vegetations. He underwent debridement and replacement of the mitral valve, followed by debridement of the left popliteal artery with peroneal artery bypass. The intraoperative cultures grew Scopulariopsis brevicaulis. Due to the resistant nature of the organism, he was initially treated with combination antifungals including liposomal amphotericin B, caspofungin, and voriconazole and was continued on chronic suppression with posaconazole with no evidence of recurrence. Scopulariopsis is a rare cause of fungal endocarditis. Treatment of Scopulariopsis endocarditis is challenging and is not well understood due to its rarity.


Journal of Clinical Virology | 2017

The role of next generation sequencing in infection prevention in human parainfluenza virus 3 infections in immunocompromised patients

Atul Kothari; Mary J. Burgess; Juan Carlos Rico Crescencio; Joshua L. Kennedy; Jesse L. Denson; Kurt Schwalm; Ashley N. Stoner; John C. Kincaid; Faith E. Davies; Darrell L. Dinwiddie

BACKGROUND Respiratory viral infections are a significant problem in patients with hematologic malignancies. We report a cluster of HPIV 3 infections in our myeloma patients, and describe the utility of next generation sequencing (NGS) to identify transmission linkages which can assist in infection prevention. OBJECTIVES To evaluate the utility of NGS to track respiratory viral infection outbreaks and delineate between community acquired and nosocomial infections in our cancer units. STUDY DESIGN Retrospective chart review conducted at a single site. All patients diagnosed with multiple myeloma who developed symptoms suggestive of upper respiratory tract infection (URTI) or lower respiratory tract infection (LRTI) along with a respiratory viral panel (RVP) test positive for HPIV 3 between April 1, 2016, to June 30, 2016, were included. Sequencing was performed on the Illumina MiSeq™. To gain understanding regarding community strains of HPIV 3 during the same season, we also performed NGS on HPIV3 strains isolated from pediatric cases. RESULTS We saw a cluster of 13 cases of HPIV3 infections in the myeloma unit. Using standard epidemiologic criteria, 3 cases were considered community acquired, 7 cases developed infection during treatment in the cancer infusion center, while an additional 3 developed infections during hospital stay. Seven patients required hospitalization for a median duration of 20days. NGS enabled sensitive discrimination of the relatedness of the isolates obtained during the outbreak and provided evidence for source of transmission. Two hospital onset infections could be tracked to an index case; the genome sequences of HPIV 3 strains from these 3 patients only differed by a single nucleotide. CONCLUSIONS NGS offers a significantly higher discriminatory value as an epidemiologic tool, and can be used to gather real-time information and identification of transmission linkages to assist in infection prevention in immunocompromised patients.


Clinical Infectious Diseases | 2017

Possible Transfusion-Transmitted Babesia divergens–like/MO-1 Infection in an Arkansas Patient

Mary J. Burgess; Eric R. Rosenbaum; Bobbi S. Pritt; Dirk T. Haselow; Katie M. Ferren; Bashar Alzghoul; Juan Carlos Rico; Lynne M. Sloan; Poornima Ramanan; Raghunandan Purushothaman; Robert W. Bradsher

A patient with asplenia and multiple red blood cell transfusions acquired babesiosis infection with Babesia divergens-like/MO-1 organisms and not Babesia microti, the common United States species. He had no known tick exposure. This is believed to be the first transfusion-transmitted case and the fifth documented case of B. divergens-like/MO-1 infection.


Transplant Infectious Disease | 2017

Skin lesion in a patient with acute myeloid leukemia

Atul Kothari; Sara C. Shalin; Juan Carlos Rico Crescencio; Mary J. Burgess

We present the case of a 51‐year‐old man with acute myeloid leukemia who developed fevers with a skin lesion following the first cycle of induction chemotherapy. Skin biopsy showed evidence of invasive fungal infection. Cultures remained negative, but polymerase chain reaction on tissue detected Rhizopus oryzae complex. The patient was started on liposomal amphotericin B and underwent surgical debridement. He was switched to posaconazole, with plans for allogeneic hematopoetic stem cell transplant in the future.


Transplant Infectious Disease | 2016

Lasiodiplodia species fungal osteomyelitis in a multiple myeloma patient.

Meera Mohan; Sara C. Shalin; Atul Kothari; Juan Carlos Rico; Kari D. Caradine; Mary J. Burgess

Lasiodiplodia species are environmental fungi that have been reported as a cause of infection in both immunocompetent and immunocompromised patients. We present a case of fungal osteomyelitis caused by Lasiodiplodia species in a patient with multiple myeloma after autologous stem cell transplant. The patient was successfully treated with a combination of surgery and oral voriconzole. To the best of our knowledge, this is the first reported case of fungal osteomyelitis caused by Lasiodiplodia species.


Journal for Healthcare Quality | 2016

Clinical study of an online tool for standardizing hospital care

Mary J. Burgess; Mark J. Enzler; Deanne T. Kashiwagi; Andi J. Selby; M. Rizwan Sohail; Paul R. Daniels; Brian D. Lahr; Farrell J. Lloyd; Larry D. Baddour

Abstract:We assessed if use of an online clinical decision support tool improved standardization and quality of care in hospitalized patients with lower extremity cellulitis (LEC). This was a 14-month preintervention and postintervention study of 85 LEC admissions. There was significantly higher usage of the online LEC care process model (CPM) in the postintervention phase (p < .001). There was a trend toward higher rates of appropriate antibiotic regimen in the postintervention group both initially and at discharge (p = .063 for both). A sensitivity analysis of CPM users versus nonusers demonstrated a significantly higher rate of appropriate initial antibiotics prescribed when the CPM was used (p < .001). Use of this online CPM was associated with improved standardization, as demonstrated by increased ordering of an appropriate initial antibiotic regimen for hospitalized patients with LEC.


Microbial Ecology | 2018

Genome-Based Comparison of Clostridioides difficile : Average Amino Acid Identity Analysis of Core Genomes

Adriana Cabal; Se-Ran Jun; Piroon Jenjaroenpun; Visanu Wanchai; Intawat Nookaew; Thidathip Wongsurawat; Mary J. Burgess; Atul Kothari; Trudy M. Wassenaar; David W. Ussery

Infections due to Clostridioides difficile (previously known as Clostridium difficile) are a major problem in hospitals, where cases can be caused by community-acquired strains as well as by nosocomial spread. Whole genome sequences from clinical samples contain a lot of information but that needs to be analyzed and compared in such a way that the outcome is useful for clinicians or epidemiologists. Here, we compare 663 public available complete genome sequences of C. difficile using average amino acid identity (AAI) scores. This analysis revealed that most of these genomes (640, 96.5%) clearly belong to the same species, while the remaining 23 genomes produce four distinct clusters within the Clostridioides genus. The main C. difficile cluster can be further divided into sub-clusters, depending on the chosen cutoff. We demonstrate that MLST, either based on partial or full gene-length, results in biased estimates of genetic differences and does not capture the true degree of similarity or differences of complete genomes. Presence of genes coding for C. difficile toxins A and B (ToxA/B), as well as the binary C. difficile toxin (CDT), was deduced from their unique PfamA domain architectures. Out of the 663 C. difficile genomes, 535 (80.7%) contained at least one copy of ToxA or ToxB, while these genes were missing from 128 genomes. Although some clusters were enriched for toxin presence, these genes are variably present in a given genetic background. The CDT genes were found in 191 genomes, which were restricted to a few clusters only, and only one cluster lacked the toxin A/B genes consistently. A total of 310 genomes contained ToxA/B without CDT (47%). Further, published metagenomic data from stools were used to assess the presence of C. difficile sequences in blinded cases of C. difficile infection (CDI) and controls, to test if metagenomic analysis is sensitive enough to detect the pathogen, and to establish strain relationships between cases from the same hospital. We conclude that metagenomics can contribute to the identification of CDI and can assist in characterization of the most probable causative strain in CDI patients.

Collaboration


Dive into the Mary J. Burgess's collaboration.

Top Co-Authors

Avatar

Atul Kothari

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Juan Carlos Rico Crescencio

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Sara C. Shalin

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Faith E. Davies

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Juan Carlos Rico

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Andrew J. Johnsrud

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Carolina Schinke

University of Arkansas for Medical Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Frits Vanrhee

University of Arkansas for Medical Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge